Skip to content
OpenCapital
Get started

Eton Pharmaceuticals, Inc. ETON Deferred Revenue

Deferred Revenue at other companies

HRO
HarrowHROW
$149K+2.8%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$1.27M-42.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.12M-65.1%
Arrowhead Research logo
Arrowhead ResearchARWR
$108.54M+151%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$69.2M-14.7%
ALN
Alnylam PharmaceuticalsALNY
$3.21M-88.6%

Segments

By product

See full
Increlex$457K-82.0%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K—
Free cash flow$7.3M+251%

Valuation

See full
Market cap$953.8M+162%
Enterprise value$965.4M+156%
P/S11×+3.4×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%—
Net margin-9.5%-2.7pp
FCF margin17.1%—

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity1×-0.2×
Current ratio1.2×-0.8×

Questions, answered.

What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.